Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201

MLA

Yamamoto, Hiromasa, et al. Randomized Phase II Study of Daily versus Alternate-Day Administrations of S-1 for the Elderly Patients with Completely Resected Pathological Stage IA (Tumor Diameter > 2 Cm)-IIIA of Non-Small Cell Lung Cancer: Setouchi Lung Cancer Group Study 1201. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1409766785&authtype=sso&custid=ns315887.

APA

Yamamoto, H., Soh, J., Okumura, N., Suzuki, H., Nakata, M., Fujiwara, T., Gemba, K., Sano, I., Fujinaga, T., Kataoka, M., Terazaki, Y., Fujimoto, N., Kataoka, K., Kosaka, S., Yamashita, M., Inokawa, H., Inoue, M., Nakamura, H., Yamashita, Y., … Toyooka, S. (2023). Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201.

Chicago

Yamamoto, Hiromasa, Junichi Soh, Norihito Okumura, Hiroyuki Suzuki, Masao Nakata, Toshiya Fujiwara, Kenichi Gemba, et al. 2023. “Randomized Phase II Study of Daily versus Alternate-Day Administrations of S-1 for the Elderly Patients with Completely Resected Pathological Stage IA (Tumor Diameter > 2 Cm)-IIIA of Non-Small Cell Lung Cancer: Setouchi Lung Cancer Group Study 1201.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1409766785&authtype=sso&custid=ns315887.